Patents by Inventor Kevin Gellenbeck

Kevin Gellenbeck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150258158
    Abstract: Compositions and methods for inhibition of triglyceride synthesis via synergistic combination of botanical extracts are described. Specifically, the present invention relates to treating or preventing weight gain or obesity, promoting weight loss, appetite suppression, or the like, as well as managing skin oil production through a synergistic inhibition of diacylglycerol acyltransferase-I (DGAT-I) enzyme involved in the triglyceride synthesis and modulation of sterol regulatory element binding protein Ic (SREBP-Ic) and/or peroxisome proliferator activated receptor gamma coactivator I-alpha (PGCI?).
    Type: Application
    Filed: February 26, 2015
    Publication date: September 17, 2015
    Applicant: Access Business Group International LLC
    Inventors: Rodney A. Velliquette, Russell Keith Randolph, Jeffrey D. Scholten, Arun Rajgopal, Kevin Gellenbeck, Chun Hu, Kerry Grann, Kristin Morris
  • Publication number: 20070243270
    Abstract: Methods of reducing cellular damage are described that include (a) administering to the mammal an oral dosage form comprising a therapeutically effective amount of a first antioxidant, and (b) administering to the mammal a topical dosage form comprising a therapeutically effective amount of a second antioxidant, wherein at least one of the first antioxidant and the second antioxidant comprises acerola concentrate. Methods of inhibiting free radical production, methods of scavenging free radicals, and kits for reducing cellular damage are also described.
    Type: Application
    Filed: January 18, 2007
    Publication date: October 18, 2007
    Inventors: Gregory Evans, Gregory Grochoski, Russell Randolph, Lynne Connor, John Scimeca, Kevin Gellenbeck, James Mayne, Haeri Roh-Schmidt, Thomas Slaga, Margareth Hanausek-Walaszek, Zbigniew Walaszek
  • Publication number: 20050100537
    Abstract: Methods of reducing cellular damage are described that include (a) administering to the mammal an oral dosage form comprising a therapeutically effective amount of a first antioxidant, and (b) administering to the mammal a topical dosage form comprising a therapeutically effective amount of a second antioxidant, wherein at least one of the first antioxidant and the second antioxidant comprises acerola concentrate. Methods of inhibiting free radical production, methods of scavenging free radicals, and kits for reducing cellular damage are also described.
    Type: Application
    Filed: November 10, 2003
    Publication date: May 12, 2005
    Inventors: Gregory Evans, Gregory Grochoski, Keith Randolph, Lynne Connor, John Scimeca, Kevin Gellenbeck, James Mayne, Haeri Roh-Schmidt, Thomas Slaga, Margaret Hanausek-Walaszek, Zbigniew Walaszek